Effectiveness of self-financed rotavirus vaccination in Ise City, Japan

References

• Parashar UD, Hummelman EG, Bresee JS, Miller MA, Glass RI. Global illness and deaths caused by rotavirus disease in children. Emerg Infect Dis. 2003;9(5):565–72. doi:10.3201/eid0905.020562.
   PubMed Web of Science ®Google Scholar
• Kamiya H, Nakano T, Kamiya H, Yui A, Taniguchi K, Parashar U; Rotavirus Epidemiology Study Group. Rotavirus-associated acute gastroenteritis hospitalizations among Japanese children aged <5 years: active rotavirus surveillance in mie prefecture, Japan. Jpn J Infect Dis. 2011;64:482–87.
   PubMed Web of Science ®Google Scholar
• Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, Abate H, Breuer T, Clemens SC, Cheuvart B, Espinoza F, Gillard P, Innis BL, et al.; Human Rotavirus Vaccine Study Group. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354(1):11–22.
   PubMed Web of Science ®Google Scholar
• Vesikari T, Matson DO, Dennehy P, Van Damme P, Santosham M, Rodriguez Z, Dallas MJ, Heyse JF, Goveia MG, Black SB, et al. Safety and efficacy of a pentavalent human-bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354(1):23–33. doi:10.1056/NEJMoa052664.
   PubMed Web of Science ®Google Scholar
• Iwata S, Nakata S, Ukae S, Koizumi Y, Morita Y, Kuroki H, Tanaka Y, Shizuya T, Schödel F, Brown ML, et al. Efficacy and safety of pentavalent rotavirus vaccine in Japan: a randomized, double-blind, placebo-controlled, multicenter trial. Hum Vaccin Immunother. 2013;9(8):1626–33. doi:10.4161/hv.24846.
   PubMed Web of Science ®Google Scholar
• Yoshikawa T, Matsuki T, Sato K, Mizuno M, Shibata M, Hasegawa S, Morita M, Iwasa M, Gopala K, Holl K. Impact of rotavirus vaccination on the burden of acute gastroenteritis in Nagoya city, Japan. Vaccine. 2018;36(4):527–34. doi:10.1016/j.vaccine.2017.12.006.
   PubMed Web of Science ®Google Scholar
• Asada K, Kamiya H, Suga S, Nagao M, Ichimi R, Fujisawa T, Umemoto M, Tanaka T, Ito H, Tanaka S, et al. Rotavirus vaccine and health-care utilization for rotavirus gastroenteritis in Tsu City, Japan. Western Pac Surveill Response J. 2016;7(4):28–36. doi:10.5365/wpsar.2016.7.3.005.
   PubMedGoogle Scholar
• Kobayashi M, Miyazaki M, Ogawa A, Tatsumi M. Sustained reduction in rotavirus-coded hospitalizations in children aged <5 years after introduction of self-financed rotavirus vaccines in Japan. Hum Vaccin Immunother. 2020;16:132–37.
   PubMed Web of Science ®Google Scholar
• Sato T, Nakagomi T, Nakagomi O. Cost-effectiveness analysis of a universal rotavirus immunization program in Japan. Jpn J Infect Dis. 2011;64:277–83.
   PubMed Web of Science ®Google Scholar
• Ledent E, Lieftucht A, Buyse H, Sugiyama K, Mckenna M, Holl K. Post-marketing benefit-risk assessment of rotavirus vaccination in Japan: a simulation and modelling analysis. Drug Saf. 2016;39(3):219–30. doi:10.1007/s40264-015-0376-7.
   PubMed Web of Science ®Google Scholar
• Dey SK, Ushijima H, Phathammavong O, Chanit W, Okitsu S, Mizuguchi M, Ota Y. Seasonal trend and serotype distribution of rotavirus infection in Japan, 1981-2008. Pediatr Infect Dis J. 2010;29:166–67. doi:10.1097/INF.0b013e3181b79460.
   PubMed Web of Science ®Google Scholar
• Ishida E. Rapidtesta Rota-Adeno. Med Technol. 2008;36(13):1402. in Japanese.
   Google Scholar
• Halloran ME, Struchiner CJ, Longini IM Jr. Study designs for evaluating different efficacy and effectiveness aspects of vaccines. Am J Epidemiol. 1997;146(10):789–803. doi:10.1093/oxfordjournals.aje.a009196.
   PubMed Web of Science ®Google Scholar
• Panozzo CA, Becker-Dreps S, Pate V, Weber DJ, Jonsson Funk M, Stürmer T, Brookhart MA. Direct, indirect, total, and overall effectiveness of the rotavirus vaccines for the prevention of gastroenteritis hospitalizations in privately insured US children, 2007–2010. Am J Epidemiol. 2014;179(7):895–909. doi:10.1093/aje/kwu001.
   PubMed Web of Science ®Google Scholar
• Weintraub ES, Baggs J, Duffy J, Vellozzi C, Belongia EA, Irving S, Klein NP, Glanz JM, Jacobsen SJ, Naleway A, et al. Risk of intussusception after monovalent rotavirus vaccination. N Engl J Med. 2014;370(6):513–19. doi:10.1056/NEJMoa1311738.
   PubMed Web of Science ®Google Scholar
• Yih WK, Lieu TA, Kulldorff M, Martin D, McMahill-Walraven CN, Platt R, Selvam N, Selvan M, Lee GM, Nguyen M. Intussusception risk after rotavirus vaccination in U.S. Infants. N Engl J Med. 2014;370(6):503–12. doi:10.1056/NEJMoa1303164.
   PubMed Web of Science ®Google Scholar
• Higashigawa M, Maeyama T, Yoshino A, Matsuda K, Ito M, Maji T, Ichimi R. Incidence of childhood primary immune thrombocytopenic purpura. Pediatr Int. 2015;57(5):1041–43. doi:10.1111/ped.12788.
   PubMed Web of Science ®Google Scholar
• Curns AT, Steiner CA, Barrett M, Hunter K, Wilson E, Parashar UD. Reduction in acute gastroenteritis hospitalizations among US children after introduction of rotavirus vaccine: analysis of hospital discharge data from 18 US states. J Infect Dis. 2010;201(11):1617–24. doi:10.1086/652403.
   PubMed Web of Science ®Google Scholar
• John TJ, Samuel R. Herd immunity and herd effect: new insights and definitions. Eur J Epidemiol. 2000;16(7):601–06. doi:10.1023/A:1007626510002.
   PubMed Web of Science ®Google Scholar
• Matthijnssens J, Ciarlet M, Rahman M, Attoui H, Bányai K, Estes MK, Gentsch JR, Iturriza-Gómara M, Kirkwood CD, Martella V, et al. Recommendations for the classification of group A rotaviruses using all 11 genomic RNA segments. Arch Virol. 2008;153(8):1621–29. doi:10.1007/s00705-008-0155-1.
   PubMed Web of Science ®Google Scholar
• Jain S, Vashistt J, Changotra H. Rotaviruses: is their surveillance needed? Vaccine. 2014;32(27):3367–78. doi:10.1016/j.vaccine.2014.04.037.
   PubMed Web of Science ®Google Scholar